Is There Risk of Stroke with Aflibercept?

被引：13

作者：

Beaumont, Paul E. ^{[1
]}

Petocz, Peter ^{[2
]}

Kang, Hyong K. ^{[1
]}

机构：

[1] Retina & Vitreous Ctr, Sydney, NSW, Australia

[2] Macquarie Univ, Fac Sci, Dept Stat, Sydney, NSW 2109, Australia

来源：

OPHTHALMOLOGY | 2014年 / 121卷 / 01期

关键词：

D O I：

10.1016/j.ophtha.2013.09.020

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：E4 / E4

页数：1

共 5 条

[1] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration [J].

Chakravarthy, Usha ;

Harding, Simon P. ;

Rogers, Chris A. ;

Downes, Susan M. ;

Lotery, Andrew J. ;

Wordsworth, Sarah ;

Reeves, Barnaby C. .

OPHTHALMOLOGY, 2012, 119 (07) :1399-1411

[2]

European Medicines Agency, 2012, 2012 ASS REP EYL AFL

[3]

Gillies MC, 2007, NEW ENGL J MED, V356, P748

[4] Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration [J].

Heier, Jeffrey S. ;

Brown, David M. ;

Chong, Victor ;

Korobelnik, Jean-Francois ;

Kaiser, Peter K. ;

Quan Dong Nguyen ;

Kirchhof, Bernd ;

Ho, Allen ;

Ogura, Yuichiro ;

Yancopoulos, George D. ;

Stahl, Neil ;

Vitti, Robert ;

Berliner, Alyson J. ;

Soo, Yuhwen ;

Anderesi, Majid ;

Groetzbach, Georg ;

Sommerauer, Bernd ;

Sandbrink, Rupert ;

Simader, Christian ;

Schmidt-Erfurth, Ursula .

OPHTHALMOLOGY, 2012, 119 (12) :2537-2548

[5] 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly [J].

Hoekstra, T ;

Geleijnse, JM ;

Kluft, C ;

Giltay, EJ ;

Kok, FJ ;

Schouten, EG .

STROKE, 2003, 34 (12) :2822-2828

← 1 →